Dataset Information

Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.

ABSTRACT:

Background

Multiple features in the presentation of randomized controlled trial (RCT) results are known to influence comprehension and interpretation. We aimed to compare interpretation of cancer RCTs with time-to-event outcomes when the reported treatment effect measure is the hazard ratio (HR), difference in restricted mean survival times (RMSTD), or both (HR+RMSTD). We also assessed the prevalence of misinterpretation of the HR.

Methods

We carried out a randomized experiment. We selected 15 cancer RCTs with statistically significant treatment effects for the primary outcome. We masked each abstract and created three versions reporting either the HR, RMSTD, or HR+RMSTD. We randomized corresponding authors of RCTs and medical residents and fellows to one of 15 abstracts and one of 3 versions. We asked how beneficial the experimental treatment was (0-10 Likert scale). All participants answered a multiple-choice question about interpretation of the HR. Participants were unaware of the study purpose.

Results

We randomly allocated 160 participants to evaluate an abstract reporting the HR, 154 to the RMSTD, and 155 to both HR+RMSTD. The mean Likert score was statistically significantly lower in the RMSTD group when compared with the HR group (mean difference -0.8, 95% confidence interval, -1.3 to -0.4, P?ConclusionMisinterpretation of the HR is common. Participants judged experimental treatments to be less beneficial when presented with RMSTD when compared with HR. We recommend that authors present RMST-based measures alongside the HR in reports of RCT results.

SUBMITTER: Weir IR

PROVIDER: S-EPMC6336004 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.

Weir I R IR Marshall G D GD Schneider J I JI Sherer J A JA Lord E M EM Gyawali B B Paasche-Orlow M K MK Benjamin E J EJ Trinquart L L

Annals of oncology : official journal of the European Society for Medical Oncology 20190101 1

<h4>Background</h4>Multiple features in the presentation of randomized controlled trial (RCT) results are known to influence comprehension and interpretation. We aimed to compare interpretation of cancer RCTs with time-to-event outcomes when the reported treatment effect measure is the hazard ratio (HR), difference in restricted mean survival times (RMSTD), or both (HR+RMSTD). We also assessed the prevalence of misinterpretation of the HR.<h4>Methods</h4>We carried out a randomized experiment. W ...[more]

PMID: 30335127

Similar Datasets

Project description:BackgroundRandomized Controlled Trials almost invariably utilize the hazard ratio calculated with a Cox proportional hazard model as a treatment efficacy measure. Despite the widespread adoption of HRs, these provide a limited understanding of the treatment effect and may even provide a biased estimate when the assumption of proportional hazards in the Cox model is not verified by the trial data. Additional treatment effect measures on the survival probability or the time scale may be used to supplement HRs but a framework for the simultaneous generation of these measures is lacking.MethodsBy splitting follow-up time at the nodes of a Gauss Lobatto numerical quadrature rule, techniques for Poisson Generalized Additive Models (PGAM) can be adopted for flexible hazard modeling. Straightforward simulation post-estimation transforms PGAM estimates for the log hazard into estimates of the survival function. These in turn were used to calculate relative and absolute risks or even differences in restricted mean survival time between treatment arms. We illustrate our approach with extensive simulations and in two trials: IPASS (in which the proportionality of hazards was violated) and HEMO a long duration study conducted under evolving standards of care on a heterogeneous patient population.FindingsPGAM can generate estimates of the survival function and the hazard ratio that are essentially identical to those obtained by Kaplan Meier curve analysis and the Cox model. PGAMs can simultaneously provide multiple measures of treatment efficacy after a single data pass. Furthermore, supported unadjusted (overall treatment effect) but also subgroup and adjusted analyses, while incorporating multiple time scales and accounting for non-proportional hazards in survival data.ConclusionsBy augmenting the HR conventionally reported, PGAMs have the potential to support the inferential goals of multiple stakeholders involved in the evaluation and appraisal of clinical trial results under proportional and non-proportional hazards.

Project description:BACKGROUND:When trials are subject to departures from randomised treatment, simple statistical methods that aim to estimate treatment efficacy, such as per protocol or as treated analyses, typically introduce selection bias. More appropriate methods to adjust for departure from randomised treatment are rarely employed, primarily due to their complexity and unfamiliarity. We demonstrate the use of causal methodologies for the production of estimands with valid causal interpretation for time-to-event outcomes in the analysis of a complex epilepsy trial, as an example to guide non-specialist analysts undertaking similar analyses. METHODS:Two causal methods, the structural failure time model and inverse probability of censoring weighting, are adapted to allow for skewed time-varying confounders, competing reasons for treatment changes and a complicated time to remission outcome. We demonstrate the impact of various factors: choice of method (structural failure time model versus inverse probability of censoring weighting), model for inverse probability of censoring weighting (pooled logistic regression versus Cox models), time interval (for creating panel data for time-varying confounders and outcome), choice of confounders and (in pooled logistic regression) use of splines to estimate underlying risk. RESULTS:The structural failure time model could adjust for switches between trial treatments but had limited ability to adjust for the other treatment changes that occurred in this epilepsy trial. Inverse probability of censoring weighting was able to adjust for all treatment changes and demonstrated very similar results with Cox and pooled logistic regression models. Accounting for increasing numbers of time-varying confounders and reasons for treatment change suggested a more pronounced advantage of the control treatment than that obtained using intention to treat. CONCLUSIONS:In a complex trial featuring a remission outcome, underlying assumptions of the structural failure time model are likely to be violated, and inverse probability of censoring weighting may provide the most useful option, assuming availability of appropriate data and sufficient sample sizes. Recommendations are provided for analysts when considering which of these methods should be applied in a given trial setting.

Dataset Information

Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.

Background

Methods

Results

Publications

Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure